Orthofix Medical (OFIX) Return on Capital Employed (2011 - 2026)
Orthofix Medical (OFIX) posted Return on Capital Employed of 6.64% for Q1 2026, up 45.26% on a QoQ basis from 12.13% in Q4 2025, and up 794.0% year-over-year from 0.74% in Q1 2025.
Orthofix Medical (OFIX) Return on Capital Employed (2011 - 2026) Analysis & Trends
Orthofix Medical's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 6.64% for Q1 2026.
- Quarterly Return on Capital Employed rose 794.0% year-over-year to 6.64% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6.64% (up 794.0% YoY) and the FY2025 annual result came in at 11.61%, down 18.0% from the prior year.
- Return on Capital Employed was 6.64% for Q1 2026 at Orthofix Medical, up from 12.13% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 1.6% in Q2 2022 and bottomed at 17.56% in Q3 2023.
- A 5-year average of 10.83% and a median of 12.83% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed sank 1449 bps — and 2026, when it surged 794 bps.
- Orthofix Medical's Return on Capital Employed stood at 3.58% in 2022, then plunged by 328 bps to 15.31% in 2023, then grew by 22 bps to 11.89% in 2024, then retreated by 2 bps to 12.13% in 2025, then surged by 45 bps to 6.64% in 2026.
- Business Quant data shows OFIX's Return on Capital Employed at 6.64% in Q1 2026, 12.13% in Q4 2025, and 13.84% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.84 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 108.95 Bn | 99.73 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 68.42 Bn | 66.97 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | 11.13% |
| 6 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | 9.30% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 24.24% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 8.38% |
| 10 | Orthofix Medical | 473.67 Mn | 352.80 Mn | 139.55 Mn | -6.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.64% |
| Dec 31, 2025 | -12.13% |
| Sep 30, 2025 | -13.84% |
| Jun 30, 2025 | -13.97% |
| Mar 31, 2025 | -14.59% |
| Dec 31, 2024 | -11.89% |
| Sep 30, 2024 | -12.83% |
| Jun 30, 2024 | -13.14% |
| Mar 31, 2024 | -14.21% |
| Dec 31, 2023 | -15.31% |
| Sep 30, 2023 | -17.56% |
| Jun 30, 2023 | -14.75% |
| Mar 31, 2023 | -12.70% |
| Dec 31, 2022 | -3.58% |
| Sep 30, 2022 | -3.06% |
| Jun 30, 2022 | -1.60% |
| Mar 31, 2022 | -2.22% |
| Dec 31, 2021 | -1.71% |
| Sep 30, 2021 | 1.13% |
| Jun 30, 2021 | 2.17% |